Elected to the Board of Directors in 2021 and Deputy Chair of the Board since 2021. Arthur is regarded as an independent board member.
Arthur is a global executive with extensive business development, marketing and leadership expertise from large healthcare companies in both the US and Europe, holding CEO positions at Bayer HealthCare and Assertio Therapeutics, and senior executive roles at Abbott Laboratories.
Senior Operating Advisor to Abu Dhabi Investment Authority, Director of Ecolab and ZimmerBiomet.
Arthur Higgins holds a B.Sc. in Biochemistry from Strathclyde University, Scotland.
British and American